taurolidine has been researched along with Cross Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, JE; Graham, N; Kleidon, T; Ullman, A | 1 |
| Cahill, J; Gerrish, M; Little, J; Taylor, C | 1 |
1 trial(s) available for taurolidine and Cross Infection
| Article | Year |
|---|---|
A new haemodialysis catheter-locking agent reduces infections in haemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Local; Catheters, Indwelling; Chi-Square Distribution; Cost of Illness; Cross Infection; Cross-Over Studies; England; Equipment Contamination; Equipment Design; Female; Humans; Incidence; Infection Control; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Renal Dialysis; Sepsis; Taurine; Therapeutic Irrigation; Thiadiazines | 2008 |
1 other study(ies) available for taurolidine and Cross Infection
| Article | Year |
|---|---|
Taurolidine-Citrate Line Locks Prevent Recurrent Central Line-Associated Bloodstream Infection in Pediatric Patients.
Topics: Adolescent; Anti-Infective Agents, Local; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Central Venous Catheters; Child; Child, Preschool; Citric Acid; Cross Infection; Female; Gram-Negative Bacteria; Humans; Infant; Male; Taurine; Thiadiazines | 2019 |